Table 3

Demographic and clinical characteristics of the study participants

CharacteristicsMean valuesGroup comparisons (p value)
Chronic fatigue group N=120CFS (CDC) subgroup N=88Healthy controls N=39Chronic fatigue group versus healthy controlsCFS (CDC) subgroup versus healthy controls
Gender
 Female (%)86 (72)64 (72)28 (72)0.980.91
Age
 Mean (SD)15.4 (1.6)15.3 (1.6)15.2 (1.6)0.570.79
 Age range, years12–1812–1812–18
BMI
 Mean (SD, Z score)21.5 (4.2, 0.4)21.2 (4.2, 0.3)20.3 (2.9)0.040.14
CDC criteria fulfilled (%)88 (73)NA
NICE criteria fulfilled (%)107 (89)NA
MFQ
 Mean (SD)17.2 (10.1)18.7 (10.4)6.6 (7.8)<0.001<0.001
Disease duration months (range)21.4 (4–104)21.1 (6–104)NANANA
CFQ
 Mean (SD)19.2 (6.2)19.9 (6.0)8.9 (4.5)<0.001<0.001
School absence
 Mean % (SD)65 (30)66 (30)2 (7)<0.001<0.001
STAI-T
 Mean (SD)42.8 (9.0)44.0 (9.1)32.1 (7.25)<0.001<0.001
KSQ
 Mean (SD)3.4 (0.97)3.3 (0.9)4.9 (0.86)<0.001<0.001
  • CFS (CDC) subgroup: Participant subgroup that meets the CDC criteria for chronic fatigue syndrome; School absence: the percentage of days out of school during the last month (20 days/month is 100%).

  • BMI, body mass index; CDC, Centers for Disease Control and Prevention; CFS, chronic fatigue syndrome; CFQ, Chalder Fatigue Questionnaire; KSQ, Karolinska Sleep Questionnaire; MFQ, Mood and Feelings Questionnaire; NICE, National Institute for Health and Care Excellence; STAI-T, Spielberger State-Trait Inventory.